Loading
PDBj
MenuPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

23SR

Cryo-EM structure of CDK2 in complex with CRBN/DDB1 and B11

This is a non-PDB format compatible entry.
Summary for 23SR
Entry DOI10.2210/pdb23sr/pdb
EMDB information69221
DescriptorProtein cereblon, Oplophorus-luciferin 2-monooxygenase catalytic subunit,Cyclin-dependent kinase 2,GFP-like fluorescent chromoprotein, DNA damage-binding protein 1, ... (4 entities in total)
Functional Keywordscyclin-dependent kinase 2, cereblon, molecular glue, complex, cell cycle
Biological sourceHomo sapiens (human)
More
Total number of polymer chains3
Total formula weight229823.46
Authors
Li, X.Z.,Jiang, Y. (deposition date: 2026-02-16, release date: 2026-07-01)
Primary citationPei, Y.,Lin, W.,Li, X.,Meng, Y.,Yin, Y.,Pan, B.,Zhou, L.,Cao, L.,Cang, Y.,Jiang, Y.,Lu, W.,Meng, Z.
Selective CDK2 Degradation via Noncanonical Recruitment.
J.Med.Chem., 2026
Cited by
PubMed Abstract: Cyclin-dependent kinase 2 (CDK2) represents a critical therapeutic target in tumors resistant to CDK4/6 inhibitors or with amplification. However, selective inhibition of CDK2 remains challenging owing to the high structural homology among CDKs. In this study, we identify and as cereblon (CRBN)-based molecular glue degraders that selectively degrade CDK2. Ternary complex structures reveal a noncanonical recruitment mode centered on CDK2 Glu57, which bypasses the canonical G-loop/β-hairpin and kinase glycine-rich loop interactions and is stabilized by an extended CRBN-CDK2 interface. Mechanistically, these degraders inhibit retinoblastoma (Rb) phosphorylation and induce G1/S-phase arrest, suppressing CDK2-dependent cell proliferation. further exhibits improved pharmacokinetics, measurable oral bioavailability, and target engagement, achieving intratumoral CDK2 degradation following intraperitoneal administration. Collectively, this study provides a structural blueprint for designing selective kinase degraders and establishes B12 as a chemically tractable probe for targeting CDK2-driven malignancies.
PubMed: 42334090
DOI: 10.1021/acs.jmedchem.6c01264
PDB entries with the same primary citation
Experimental method
ELECTRON MICROSCOPY (2.85 Å)
Structure validation
No wwPDB Validation report is currently available for this entry.

255900

PDB entries from 2026-07-01

PDB statisticsPDBj update infoContact PDBjnumon